185 related articles for article (PubMed ID: 9754544)
21. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
Arya SC
Am J Trop Med Hyg; 2001 Dec; 65(6):v-vi. PubMed ID: 11792007
[No Abstract] [Full Text] [Related]
22. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).
Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B
J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494
[TBL] [Abstract][Full Text] [Related]
23. Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice.
Jackson AC; Rossiter JP
Acta Neuropathol; 1997 Apr; 93(4):349-53. PubMed ID: 9113200
[TBL] [Abstract][Full Text] [Related]
24. Tunicamycin enhances neuroinvasion and encephalitis in mice infected with Venezuelan equine encephalitis virus.
Steele KE; Seth P; Catlin-Lebaron KM; Schoneboom BA; Husain MM; Grieder F; Maheshwari RK
Vet Pathol; 2006 Nov; 43(6):904-13. PubMed ID: 17099147
[TBL] [Abstract][Full Text] [Related]
25. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.
Julander JG; Skirpstunas R; Siddharthan V; Shafer K; Hoopes JD; Smee DF; Morrey JD
Antiviral Res; 2008 Jun; 78(3):230-41. PubMed ID: 18313150
[TBL] [Abstract][Full Text] [Related]
26. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
27. Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis.
Schäfer A; Whitmore AC; Konopka JL; Johnston RE
J Virol; 2009 May; 83(9):4275-86. PubMed ID: 19225006
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.
Hollidge BS; Cohen CA; Akuoku Frimpong J; Badger CV; Dye JM; Schmaljohn CS
Virulence; 2021 Dec; 12(1):430-443. PubMed ID: 33487119
[TBL] [Abstract][Full Text] [Related]
30. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
White LJ; Wang JG; Davis NL; Johnston RE
J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360
[TBL] [Abstract][Full Text] [Related]
31. Spread of Venezuelan equine encephalitis virus in mice olfactory tract.
Ryzhikov AB; Ryabchikova EI; Sergeev AN; Tkacheva NV
Arch Virol; 1995; 140(12):2243-54. PubMed ID: 8572944
[TBL] [Abstract][Full Text] [Related]
32. Venezuelan equine encephalitis virus: comparison of infectivity and virulence of strains V-38 and P676 in donkeys.
Mackenzie RM; de Siger J; Parra D
Am J Trop Med Hyg; 1976 May; 25(3):494-9. PubMed ID: 937636
[TBL] [Abstract][Full Text] [Related]
33. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
Bennett AM; Lescott T; Phillpotts RJ
Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
[TBL] [Abstract][Full Text] [Related]
34. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins.
Spotts DR; Reich RM; Kalkhan MA; Kinney RM; Roehrig JT
J Virol; 1998 Dec; 72(12):10286-91. PubMed ID: 9811777
[TBL] [Abstract][Full Text] [Related]
35. Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics.
Gonzalez-Salazar D; Estrada-Franco JG; Carrara AS; Aronson JF; Weaver SC
Emerg Infect Dis; 2003 Feb; 9(2):161-8. PubMed ID: 12603985
[TBL] [Abstract][Full Text] [Related]
36. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.
Davis NL; Grieder FB; Smith JF; Greenwald GF; Valenski ML; Sellon DC; Charles PC; Johnston RE
Arch Virol Suppl; 1994; 9():99-109. PubMed ID: 8032286
[TBL] [Abstract][Full Text] [Related]
37. Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.
Montiel M; Bonilla E; Valero N; Mosquera J; Espina LM; Quiroz Y; Álvarez-Mon M
Antivir Chem Chemother; 2015 Aug; 24(3-4):99-108. PubMed ID: 27503577
[TBL] [Abstract][Full Text] [Related]
38. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.
MacDonald GH; Johnston RE
J Virol; 2000 Jan; 74(2):914-22. PubMed ID: 10623754
[TBL] [Abstract][Full Text] [Related]
39. [The course of airborne infection in rabbits infected with the Venezuelan encephalomyelitis virus].
Sergeev AN; Ryzhikov AB; Bulychev LE; Stepkina EO; Tkacheva NV
Vopr Virusol; 1991; 36(6):492-5. PubMed ID: 1785185
[TBL] [Abstract][Full Text] [Related]
40. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
